These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 31613330)
1. Toward Improving Practices for Submission of Diagnostic Tissue Blocks for National Cancer Institute Clinical Trials. Makhlouf H; Watson MA; Lankes HA; Weil C; Dickler M; Birrer M; Moskaluk C; Ramirez NC; Okby N; Alonsozana E; Barnes M; Goldman EB; Enos R; Lubensky I Am J Clin Pathol; 2020 Jan; 153(2):149-155. PubMed ID: 31613330 [TBL] [Abstract][Full Text] [Related]
2. Recommendations for collection and handling of specimens from group breast cancer clinical trials. Leyland-Jones BR; Ambrosone CB; Bartlett J; Ellis MJ; Enos RA; Raji A; Pins MR; Zujewski JA; Hewitt SM; Forbes JF; Abramovitz M; Braga S; Cardoso F; Harbeck N; Denkert C; Jewell SD; ; ; ; ; ; ; ; ; ; ; ; J Clin Oncol; 2008 Dec; 26(34):5638-44. PubMed ID: 18955459 [TBL] [Abstract][Full Text] [Related]
3. Factors that drive the increasing use of FFPE tissue in basic and translational cancer research. Gaffney EF; Riegman PH; Grizzle WE; Watson PH Biotech Histochem; 2018; 93(5):373-386. PubMed ID: 30113239 [TBL] [Abstract][Full Text] [Related]
4. A review of preanalytical factors affecting molecular, protein, and morphological analysis of formalin-fixed, paraffin-embedded (FFPE) tissue: how well do you know your FFPE specimen? Bass BP; Engel KB; Greytak SR; Moore HM Arch Pathol Lab Med; 2014 Nov; 138(11):1520-30. PubMed ID: 25357115 [TBL] [Abstract][Full Text] [Related]
5. Tissue Contamination During Transportation of Formalin-Fixed, Paraffin-Embedded Blocks. Carll T; Fuja C; Antic T; Lastra R; Pytel P Am J Clin Pathol; 2022 Jul; 158(1):96-104. PubMed ID: 35195717 [TBL] [Abstract][Full Text] [Related]
6. Enrolling Older Adults Onto National Cancer Institute-Funded Clinical Trials in Community Oncology Clinics: Barriers and Solutions. Hopkins JO; Braun-Inglis C; Guidice S; Wells M; Moorthi K; Berenberg J; St Germain D; Mohile S; Hudson MF J Natl Cancer Inst Monogr; 2022 Dec; 2022(60):117-124. PubMed ID: 36519815 [TBL] [Abstract][Full Text] [Related]
7. Toward Improving Practices for Submission of Diagnostic Tissue Blocks for National Cancer Institute Clinical Trials. Mccall SJ Am J Clin Pathol; 2020 Jan; 153(2):146-148. PubMed ID: 31586436 [No Abstract] [Full Text] [Related]
8. National Cancer Institute's Precision Medicine Initiatives for the new National Clinical Trials Network. Abrams J; Conley B; Mooney M; Zwiebel J; Chen A; Welch JJ; Takebe N; Malik S; McShane L; Korn E; Williams M; Staudt L; Doroshow J Am Soc Clin Oncol Educ Book; 2014; ():71-6. PubMed ID: 24857062 [TBL] [Abstract][Full Text] [Related]
9. The NCI All Ireland Cancer Conference. Johnston PG; Daly PA; Liu E Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862 [TBL] [Abstract][Full Text] [Related]
12. The Biospecimen Preanalytical Variables Program: A Multiassay Comparison of Effects of Delay to Fixation and Fixation Duration on Nucleic Acid Quality. Carithers LJ; Agarwal R; Guan P; Odeh H; Sachs MC; Engel KB; Greytak SR; Barcus M; Soria C; Lih CJ; Williams PM; Branton PA; Sobin L; Fombonne B; Bocklage T; Andry C; Duffy ER; Sica G; Dhir R; Jewell S; Roche N; Moore HM; Arch Pathol Lab Med; 2019 Sep; 143(9):1106-1118. PubMed ID: 30785788 [TBL] [Abstract][Full Text] [Related]
13. Are there barriers to the release of paraffin blocks for clinical research trials? A College of American Pathologists survey of 609 laboratories. Fitzgibbons PL Arch Pathol Lab Med; 2011 Jul; 135(7):870-3. PubMed ID: 21732776 [TBL] [Abstract][Full Text] [Related]
14. Proposals for uniform collection of biospecimens from neoadjuvant breast cancer clinical trials: timing and specimen types. Loi S; Symmans WF; Bartlett JM; Fumagalli D; Van't Veer L; Forbes JF; Bedard P; Denkert C; Zujewski J; Viale G; Pusztai L; Esserman LJ; Leyland-Jones BR Lancet Oncol; 2011 Nov; 12(12):1162-8. PubMed ID: 21684810 [TBL] [Abstract][Full Text] [Related]
15. Tissue fixed with formalin and processed without paraffin embedding is suitable for imaging of both peptides and lipids by MALDI-IMS. Pietrowska M; Gawin M; Polańska J; Widłak P Proteomics; 2016 Jun; 16(11-12):1670-7. PubMed ID: 27001204 [TBL] [Abstract][Full Text] [Related]
16. State of the Art: Toward Improving Outcomes of Lung and Liver Tumor Biopsies in Clinical Trials-A Multidisciplinary Approach. Levy EB; Fiel MI; Hamilton SR; Kleiner DE; McCall SJ; Schirmacher P; Travis W; Kuo MD; Suh RD; Tam AL; Islam SU; Ferry-Galow K; Enos RA; Doroshow JH; Makhlouf HR J Clin Oncol; 2020 May; 38(14):1633-1640. PubMed ID: 32134701 [TBL] [Abstract][Full Text] [Related]
17. High-resolution copy number profiling by array CGH using DNA isolated from formalin-fixed, paraffin-embedded tissues. van Essen HF; Ylstra B Methods Mol Biol; 2012; 838():329-41. PubMed ID: 22228020 [TBL] [Abstract][Full Text] [Related]
18. Ongoing Use of Data and Specimens From National Cancer Institute-Sponsored Cancer Prevention Clinical Trials in the Community Clinical Oncology Program. Minasian LM; Tangen CM; Wickerham DL Semin Oncol; 2015 Oct; 42(5):748-63. PubMed ID: 26433556 [TBL] [Abstract][Full Text] [Related]
19. Making the most of pathological specimens: molecular diagnosis in formalin-fixed, paraffin embedded tissue. Fairley JA; Gilmour K; Walsh K Curr Drug Targets; 2012 Nov; 13(12):1475-87. PubMed ID: 22974391 [TBL] [Abstract][Full Text] [Related]
20. Feasibility of a Centralized Clinical Trials Coverage Analysis: A Joint Initiative of the American Society of Clinical Oncology and the National Cancer Institute. Szczepanek CM; Hurley P; Good MJ; Denicoff A; Willenberg K; Dawson C; Kurbegov D J Oncol Pract; 2017 Jun; 13(6):395-400. PubMed ID: 28481681 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]